Summary: Darshak Dholakia, a partner in Dechert’s Washington office, provides a timely overview of the current Committee on Foreign Investment in the United States (CFIUS) approach to foreign investment in the US, comparable laws of other countries and how scrutiny of healthcare and biotechnology sectors may increase in light of the COVID-19 pandemic.
